hATTR Amyloidosis: A Rare Condition Disproportionately Affecting African Americans
In partnership with The Balm in Gilead, the goal of this webinar is to provide education about hereditary ATTR (hATTR) amyloidosis, a rare condition disproportionately affecting African Americans.
Join us to hear from Dr. Ike Okwuosa, a healthcare professional experienced in the management of hATTR amyloidosis, and Jean, a patient living with this rare, genetic disease. Approximately 1 in 25 (4%) of African Americans have a certain genetic variant associated with hATTR amyloidosis. Learn how to recognize the signs and symptoms of the disease, how it’s passed down, and where to find additional educational resources.
There is no cost to attend this virtual event.
May 10, 2022 06:30 PM in Eastern Time (US and Canada)
The Bridge and its associated logo are trademarks of Alnylam Pharmaceuticals, Inc.
© 2022 Alnylam Pharmaceuticals, Inc. All rights reserved. NP-USA-00341-V2
Ike Okwuosa, MD
Advanced Heart Failure & Transplant Cardiologist at Northwestern Medicine
Alnylam Patient Education Liaison at Alnylam Pharmaceuticals, Inc.
Jean, living with hATTR amyloidosis
© 2012-2030 The Balm In Gilead, Inc. | This Web site may contain messages that are inappropriate for some audiences. Since HIV and other communicable diseases are spread primarily through sexual behavior or by sharing needles, content on this site may address these topics. If you are not seeking such information or may be offended by such materials, please exit this Web site. While we aim to provide accurate and up-to-date content on this site, it may contain errors or omissions, as information about HIV/AIDS and other health disparities frequently changes. This site may also contain content from third party sources and/or links to content on other sites. The Balm In Gilead is not responsible for such content.